Morgan Stanley Maintains Equal-Weight on Ovintiv, Lowers Price Target to $46

Benzinga · 10/14/2025 16:09
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Equal-Weight and lowers the price target from $48 to $46.